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Nevoid basal cell carcinoma syndrome (NBCCS), or Gorlin Syndrome, is an autosomal dominant multisystem disorder, characterized
by multiple developmental abnormalities and inactivation germline mutations in the human homolog of the patched (PTCH) gene. We
are presenting a case of NBCCS in a skin type 4 Saudi male with a novel PTCH1 gene mutation. To the best of our knowledge, this is the
third case reported in Saudi Arabia but the ﬁrst in adult population. Moreover, our patient harbors a novel heterozygosity mutation in
patch1 gene.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Nevoid basal cell carcinoma syndrome (NBCCS), basal
cell nevus syndrome, or Gorlin Syndrome [OMIM, 109400]
refer to the same rare genetic mulitsystemic disorder. Inher-
itance is autosomal dominant with near-complete pene-
trance and variable expression. It is characterized by
multiple developmental abnormalities and inactivation
germline mutations in the human homolog of the patched
(PTCH) gene. NBCCS can involve skin, bone and the ner-
vous system. Major features include multiple basal cellhttp://dx.doi.org/10.1016/j.jdds.2015.08.001
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Production and hosting by Elseviercarcinomas (BCC); odontogenic keratocysts; palm and/or
sole pits and calciﬁcation of the falx cerebri. Other features
include as well cleft lip or palate, microphthalmos, a biﬁd
or fused rib, scoliosis, tall stature, frontal bossing and
medulloblastoma.
It is a rare condition in the dark skin population. To the
best of our knowledge, herein, we report the third case of
NBCCS in Saudi population and the ﬁrst one in the adult-
hood with a novel PTCH1 gene mutation.2. Case report
A 38 year-old male soldier from AlJouf, North of Saudi
Arabia, presented with a history of multiple biopsy-proven
pigmented BCCs overlying the abdomen, scalp, and right
shoulder one year ago. Since then, he developed more
BCCs over the same areas. He spent signiﬁcant time out-
side without sun protection. There was no trauma, ionizing
radiation, or exposure to chemicals. He is a heavy smoker.
Family history is positive for non-consanguinity and abehalf of King Saud University.
commons.org/licenses/by-nc-nd/4.0/).
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undiagnosed.
Upon skin examination, multiple, >20 pigmented
(black) papulo-nodular lesions were found on the scalp
with variability in size, Fig. 1. Skin tags were present. There
was frontal bossing, with conﬂuent eyebrows (Fig. 1inset b)
and tall stature (184 cm). There were numerous bilateral
plantar (Fig. 1inset c) pits.
NBCCSwas suspected based on the clinical presentation.
X-rays of the face revealed well-deﬁned lytic bony lesions
involving the mandible. CT of the head suggested odonto-
genic bony keratocysts of the mandible and maxillary bones
aswell as extensive calciﬁcation of the falx cerebri. Therewas
no evidence of cardiac ﬁbromas on echocardiogram. Conﬁr-
mation with a genetic study showed positivity for a haploin-
suﬃciency with novel partial deletion (EXON 13) of the
PTCH1 gene. Therefore, nevoid basal cell carcinoma
syndrome was conﬁrmed. BCCs were treated with surgical
excision and curettage.3. Discussion
NBCCS is a rare inherited multisystem condition caused
by germline mutations in the PTCH gene (Cohen, 1999).
Jarisch and White ﬁrst described it in 1894, which was later
followed by greater establishment of the syndrome by
Gorlin and Goltz (1960). It has the estimated prevalence
of 1:57000 to 1:164000 individuals. It aﬀects both genders
equally, with greater incidence in Caucasians and less in
blacks and Asians (Goldstein et al., 1994; Ahn et al.,
2004). Extensive literature review identiﬁed two pediatric
cases in the Saudi population while our patient is the ﬁrst
case diagnosed in adulthood.
Interestingly, more than one hundred clinical ﬁndings
have been reported in the English literature. The diagnosis
is clinical, and is supported by the presence of two major,
or one major and two minor criteria (Table 1) Evans et al.
(1993). Major manifestations are found in 75–80% of cases,
and include early development of basal cell carcinomas;Fig. 1. Multiple BCCs over the scalp. Inset b: frontal bossing. Inset c:
plantar pits.odontogenic keratocysts; palm and/or plantar pitting; ecto-
pic calciﬁcation of the falx cerebri; and family history of
NBCCS (Evans et al., 1993). Minor criteria include biﬁd
ribs; craniofacial anomalies such as coarse facial features,
macrocephaly, frontal bossing, conﬂuent brows, and hyper-
telorism; early onset midline medulloblastoma; ovarian or
cardiac ﬁbromas; lymphomesenteric cysts; and congenital
malformations like cleft lip or palate, polydactyly, eye
abnormalities, cataracts, glaucoma, and coloboma (Evans
et al., 1993). Diagnosis can be diﬃcult in young patients,
and atypical cases in persons with dark complexion.
Skin manifestations include BCCs, palmoplantar pits,
milia, hemangiomas, and skin tags (Walling et al., 2004).
BCC occurs in approximately 75% of NBCCS Caucasian
patients and are multiple (Kimonis et al., 1997). Interest-
ingly, one-third of all sporadic basal cell carcinomas have
mutations in the PTCH gene (Gailani et al., 1996). In
NBCCS, the age at ﬁrst diagnosis ranges from three to
53 years with the mean average of 20–21 (Kimonis et al.,
1997). The histopathological examination of gorlins’ BCCs
is indistinct from sporadic cases (Gorlin, 2004). In this syn-
drome, BCCs are largely evident in Caucasians (80%) than
in black (30–40%) or Asian individuals (Goldstein et al.,
1994; Ahn et al., 2004; Kulkarni et al., 2003). This ﬁnding
is principally expected because darker skinned populations
are intrinsically resistant to UV light.
Palmoplantar pits are a common feature. They are sec-
ondary to partial or complete absence of the horny cell
layer of the skin (Howell and Mehregan, 1970). Odonto-
genic keratocysts occur mainly in the mandible, and unlike
BCCs, share no racial predilection (Goldstein et al., 1994).
Ectopic calciﬁcation occurs in the falx cerebri in 65% of
patients with rates increasing to 90% in those over 40 years
old (Kimonis et al., 1997). Our patient had all major and
some minor criteria for diagnosis in addition to tall stature,
frontal bossing, and coarse facial features were present.
NBCCS must be distinguished from other rare genoder-
matosis with malignant potential e.g., Bazex, Rombo,
Muir-torre syndrome, Xeroderma pigmentosum and Basa-
loid follicular hamartomas (BFH). Bazex syndrome is a
X-linked condition characterized by multiple BCCs,
hypotrichosis, hypohidrosis and acral follicular atropho-
derma (Hauck and Manders, 1994). Rombo syndrome is
characterized by multiple BCCs, vermiculate atropho-
derma, milia, hypotrichosis, trichoepitheliomas and periph-
eral cyanosis (Hauck and Manders, 1994). Muir-Torre
syndrome is an autosomal dominant condition with vari-
ous skin sebaceous neoplasms and visceral malignancies
(Hauck and Manders, 1994).
NBCCS results from mutations in the PTCH gene, the
human homolog of Drosophila. It exhibits autosomal dom-
inance with near-complete penetrance but is variably
expressed (Anderson et al., 1967). The patched gene is
located in the long arm of chromosome 9 (Farndon et al.,
1992). The transcribed PTCH protein is part of a receptor
complex (with Smoothened, SMO) for the hedgehog pro-
tein, part of the sonic hedgehog-signaling pathway (Stone
Table 2
Comparison of characteristics in NBCCS reports in Saudi Arabia (Alghamdi, 2008; Hellani et al., 2009).
Characteristic Our patient Hellani et al. Alghamdi
Age and gender 38 years, male 15 years, male 10, 8, 6 years old, female siblings








Family history +  
Minor ﬁndings Frontal bossing, skin tags, coarse facies, tall
stature, conﬂuent eyebrows
Frontal bossing, conﬂuent eyebrows, pectus
excavatum, biﬁd ribs, spina biﬁda
Frontal bossing, skin tags, coarse
facies, hydrocephalus
Gene +PTCH1, exon 13 deletion +PTCH1, de novo mutation (c.1291delC) Not reported
Table 1
Major and minor clinical features (Evans et al., 1993).
Major features Minor features
 Multiple basal cell carcinomas or Basal cell carcinoma before
age 20
 Craniofacial anomalies: macrocephaly, frontal bossing, hypertelorism
 Odontogenic keratocysts conﬁrmed by histology  Biﬁd, or splayed ribs
 Palmar or plantar pits (>3)  Early onset medulloblastoma
 Ectopic bilamellar calciﬁcation of the falx cerebri  Fibroma: ovarian, or cardiac
 Positive family history  Lymphomesenteric cysts
 Congenital malformations: cleft lip/palate, eye abnormalities, hand and ﬁnger
abnormalities
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the fact that PTCH1 mRNA is abundant in odontogenic
keratocysts and BCCs from Gorlin Syndrome patients but
not in other skin neoplasms (Nagano et al., 1999). Gorlin
Syndrome patients are abnormally sensitive to therapeutic
doses of ionizing radiation, with development of numerous
BCCs in the irradiated site shortly after exposure (Evans
et al., 1993). Our patient had a novel PTCH1 gene mutation
result by array-based comparative genomic hybridization
(aCGH) in the form of deletion of exon 13.
NBCCS patients should be managed by a multidisci-
plinary team (Lo Muzio et al., 1999). BCC should be trea-
ted with surgery if possible. However, other destructive
modalities or topical immunomodulators can be used. Vis-
modegib is a speciﬁc oral SHH pathway component inhibi-
tor that can be used in diﬃcult to treat or metastatic cases
(Tang et al., 2012). Sun protection and close surveillance
are essentials (Frentz et al., 1987).
In Saudi Arabia, two reports of pediatric NBCCS were
identiﬁed. Alghamdi reported a family with three sisters with
Gorlin Syndrome (Alghamdi, 2008). Another report byHel-
lani et al. identiﬁed a 15-year-oldmale withNBCCS (Hellani
et al., 2009) (Table 2). To the best of our knowledge, our
patient is considered the ﬁrst reported case of Adult NBCCS
in the kingdom of Saudi Arabia and the establishment of a
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